Predicting treatment outcomes in CLL

Abstract

In this issue of Blood, Stilgenbauer and colleagues report on the prognostic and predictive value of gene mutations assessed prospectively in patients with chronic lymphocytic leukemia (CLL) treated with first-line chemoimmunotherapy. © 2014 by The American Society of Hematology.